Current Situation and Global Perspective of Nipah Virus

Authors

  • Erni Juwita Nelwan Division of Tropical Medicine and Infectious Diseases, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia – Cipto Mangunkusumo Hospital, Jakarta, Indonesia

Keywords:

Nipah virus, zoonotic diseases, emerging infections, encephalitis, outbreak preparedness

Abstract

The Nipah virus (NiV) is a highly pathogenic zoonotic virus associated with recurrent outbreaks in South and Southeast Asia. Since its first identification in 1998 among the pig farmers in Sungai Nipah Village in Malaysia, NiV has demonstrated high case fatality rates (40–75%) and significant epidemic potential. At that time, the virus spread to Singapore, and human cases were also identified in India, Bangladesh, and Philippine afterwards. No human cases have been reported in Indonesia; the country remains on high alert due to geographic concerns and the intensity of mobilization of people. To review the current global epidemiological situation of Nipah virus (as of 2026), evaluate public health preparedness, and analyze ongoing research efforts, including vaccine and therapeutic development.Nipah virus outbreaks remain geographically concentrated in Bangladesh and India, with seasonal spillover events linked primarily to bat-to-human transmission through contaminated food products. Human-to-human transmission occurs but remains limited. Improved surveillance, rapid case isolation, and contact tracing have reduced outbreak sizes in recent years. Vaccine candidates are currently in Phase II clinical trials.While the global pandemic risk remains low at present, the Nipah virus continues to represent a high-consequence emerging pathogen. Sustained surveillance, vaccine development, ecological research, and strengthened health systems are critical to mitigating future risks.

References

World Health Organization. Nipah virus fact sheet. WHO; 2024.

Chua KB, Bellini WJ, Rota PA, et al. Nipah virus: a recently emergent deadly paramyxovirus. Science. 2000;288(5470):1432-5.

Halpin K, Hyatt AD, Fogarty R, et al. Pteropid bats are confirmed as the reservoir hosts of henipaviruses: a comprehensive experimental study of virus transmission. Am J Trop Med Hyg. 2011; 85(5):946-51.

Shresta L. Nipah virus: an overview. Microbe Notes. 2026. Available online: https://microbenotes.com/nipah-virus-niv/

Luby SP, Hossain MJ, Gurley ES, et al. Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007. Emerg Infect Dis. 2009; 15(8) 1229-35.

Hossain MJ, Gurley ES, Montgomery JM, et al. Clinical presentation of Nipah virus infection in Bangladesh. Clin Infect Dis. 2008; 46(7):977-84.

Hassan MZ, Ibrahim SK, Harriss E, et.al. Interpreting the natural history and pathogenesis of Nipah virus disease through clinical data, to inform clinical trial design: a systematic review. The Lancet Microbe. 2026.

Nahar N, Paul RC, Sultana R, et al. Raw sap consumption habits and its association with knowledge of Nipah virus in two endemic districts in Bangladesh. PLoS Med. 2015.

Sun B, Jia L, Liang B, et.al. Phylogeography, transmission, and viral proteins of Nipah virus. Virol Sin. 2018;33:385-93.

Government of India Ministry of Health. Nipah outbreak situation reports, 2023–2026.

Oxford Vaccine Group. ChAdOx1 Nipah vaccine trial update; 2025.

Geisbert TW, Mire CE, Geisbert JB, et al. Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody. Sci Transl Med. 2014; 6(242):242ra82.

Plowright RK, Eby P, Hudson PJ, et al. Ecological dynamics of emerging bat virus spillover. Proc Biol Sci. 2015; 282 (1798):20142124.

Downloads

Published

2026-04-09

How to Cite

Nelwan, E. J. (2026). Current Situation and Global Perspective of Nipah Virus. Acta Medica Indonesiana, 58(1), 107. Retrieved from https://mail.actamedindones.org/index.php/ijim/article/view/3375

Most read articles by the same author(s)

1 2 > >>